Levothyroxine Sodium Tablet
Product Images NDC 67296-2046

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Levothyroxine Sodium (NDC 67296-2046). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label-100-mcg-90-tab (Levothyroxine 100 Mcg 90 Tab)

Label-100-mcg-90-tab (Levothyroxine 100 Mcg 90 Tab)
Not available.*
FDA Label Image

Label-112-mcg-90-tab (Levothyroxine 112 Mcg 90 Tab)

FDA Label Image

Label-125-mcg-90-tab (Levothyroxine 125 Mcg 90 Tab)

Label-125-mcg-90-tab (Levothyroxine 125 Mcg 90 Tab)
Each tablet contains 125 meg (0.125 mg) of levothyroxine sodium USP. The tablets should be stored between 20°C to 25°C (68°F to 77°F) with excursions permitted to 15°C to 30°C (59°F to 86°F). They should be protected from light and moisture. The tablets are manufactured by Intas Pharmaceuticals Limited in India. The manufacturing license number is 15/UA/SC/P-2006. The tablets are supplied in a light-resistant container. Do not accept the tablets if the seal over the bottle opening is broken or missing. The product is manufactured for Accord Healthcare, Inc. and it is intended for prescription use.*
FDA Label Image

Label-137-mcg-90-tab (Levothyroxine 137 Mcg 90 Tab)

Label-137-mcg-90-tab (Levothyroxine 137 Mcg 90 Tab)
This text provides information about a medication called Levothyroxine Sodium Tablets. Each tablet contains 137 mcg (0.137 mg) of levothyroxine sodium USP. The package insert should be consulted for full prescribing information. The tablets should be stored at a temperature between 20°C to 25°C (68°F to 77°F) with excursions permitted to 15°C to 30°C (59°F to 86°F). The medication should be protected from light and moisture and dispensed in a tight, light-resistant container. It should not be accepted if the seal over the bottle opening is broken or missing. The medication is manufactured for Accord Healthcare, Inc. in Durham, NC, and manufactured by Intas Pharmaceuticals Limited in India. The text also includes a unique NDC code, the quantity of tablets in the bottle, and manufacturing license information.*
FDA Label Image

Label-150-mcg-90-tab (Levothyroxine 150 Mcg 90 Tab)

Label-150-mcg-90-tab (Levothyroxine 150 Mcg 90 Tab)
Each tablet contains 150 mcg (0.15 mg) of levothyroxine sodium USP. The tablets should be stored between 20°C and 25°C (68°F to 77°F), with excursions permitted between 15°C and 30°C (59°F to 86°F). It is important to protect the tablets from light and moisture. The manufacturer is Intas Pharmaceuticals Limited, located in Dehradun, India. The tablets should be kept in a light-resistant container. The product is manufactured for Accord Healthcare, Inc.*
FDA Label Image

Label-175-mcg-90-tab (Levothyroxine 175 Mcg 90 Tab)

Label-175-mcg-90-tab (Levothyroxine 175 Mcg 90 Tab)
Each tablet contains 175 mcg (0.175 mg) of levothyroxine sodium. The tablets are meant for prescription use only. The product should be stored at a temperature between 20°C and 25°C (68°F to 77°F), with temporary excursions permitted between 15°C and 30°C (59°F to 86°F). It should also be protected from light and moisture. The tablets should be dispensed in a tightly sealed, light-resistant container. The product is manufactured by Accord Healthcare, Inc. and Intas Pharmaceuticals Limited. NDC number: 1 6729'456'15. For more information, refer to the package insert.*
FDA Label Image

Label-200-mcg-90-tab (Levothyroxine 200 Mcg 90 Tab)

FDA Label Image

Label-25-mcg-90-tab (Levothyroxine 25 Mcg 90 Tab)

FDA Label Image

Label-300-mcg-90-tab (Levothyroxine 300 Mcg 90 Tab)

Label-300-mcg-90-tab (Levothyroxine 300 Mcg 90 Tab)
Each tablet contains 300 mcg (0.3 mg) of levothyroxine sodium. The tablets should be stored at a temperature between 20°C to 25°C (68°F to 77°F), with excursions permitted to 15°C to 30°C (59°F to 86°F). They should be protected from light and moisture and dispensed in a tight, light-resistant container. The tablets should not be accepted if the seal over the bottle opening is broken or missing. The tablets are manufactured by Intas Pharmaceuticals Limited in India for Accord Healthcare, Inc. The National Drug Code (NDC) for these tablets is 16729-458-15. The package contains 90 tablets. The manufacturing license number is 15/UA/SC/P-2006.*
FDA Label Image

Label-50-mcg-90-tab (Levothyroxine 50 Mcg 90 Tab)

FDA Label Image

Label-75-mcg-90-tab (Levothyroxine 75 Mcg 90 Tab)

FDA Label Image

Label-88-mcg-90-tab (Levothyroxine 88 Mcg 90 Tab)

FDA Label Image

Description (Levothyroxine Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.